| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS10001966 | HBV | ENSG00000108381.11 | protein_coding | ASPA | No | No | 443 | P45381 Q6FH48 |
| TVIS10023334 | HBV | ENSG00000108381.11 | protein_coding | ASPA | No | No | 443 | P45381 Q6FH48 |
| TVIS10027718 | HBV | ENSG00000108381.11 | protein_coding | ASPA | No | No | 443 | P45381 Q6FH48 |
| TVIS10053086 | HBV | ENSG00000108381.11 | protein_coding | ASPA | No | No | 443 | P45381 Q6FH48 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | ASPA |
|---|---|
| DrugBank ID | DB14487 |
| Drug Name | Zinc acetate |
| Target ID | BE0000187 |
| UniProt ID | P45381 |
| Regulation Type | |
| PubMed IDs | 17027983; 17194761 |
| Citations | Herga S, Berrin JG, Perrier J, Puigserver A, Giardina T: Identification of the zinc binding ligands and the catalytic residue in human aspartoacylase, an enzyme involved in Canavan disease. FEBS Lett. 2006 Oct 30;580(25):5899-904. Epub 2006 Oct 2.@@Bitto E, Bingman CA, Wesenberg GE, McCoy JG, Phillips GN Jr: Structure of aspartoacylase, the brain enzyme impaired in Canavan disease. Proc Natl Acad Sci U S A. 2007 Jan 9;104(2):456-61. Epub 2006 Dec 28. |
| Groups | Approved; Investigational |
| Direct Classification | |
| SMILES | [Zn++].CC([O-])=O.CC([O-])=O |
| Pathways | |
| PharmGKB | |
| ChEMBL | CHEMBL1200928 |
